What will be the absolute efficacy of the single-dose Johnson & Johnson Ad26.COV2.S vaccine candidate according to the results of Phase III testing?
Resolved:
54.6
73.7
1d
1w
2m
all
Based on 18 predictions by 12 forecasters
Metaculus